Intervention for Sleep and Pain in Youth: a Randomized Controlled Trial
I-SPY-RCT
Enhancing the Efficacy of Migraine Self-Management in Children with Comorbid Insomnia
1 other identifier
interventional
224
1 country
1
Brief Summary
Insomnia is a common comorbidity among adolescents with migraine. This randomized controlled clinical trial aims to determine efficacy of cognitive-behavioral therapy (CBT) for insomnia, as well as the combined effect of CBT insomnia and pain interventions, on reducing insomnia symptoms and headache-related disability in adolescents with migraine. The long-term goal is to offer effective, tailored self-management interventions that can address migraine and co-morbid sleep problems in adolescence and disrupt a cycle of persistent, disabling migraine from continuing into adulthood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedDecember 17, 2024
December 1, 2024
3.4 years
June 8, 2021
December 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in insomnia symptoms
The 7-item Insomnia Severity Index (ISI) measures severity of insomnia symptoms. Total scores above 8 on the ISI indicate clinically significant insomnia in adult and adolescent samples.
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in headache-related disability
The CALI-9 is a 9-item self-report instrument of headache-related disability in children and adolescents that measures difficulty in performing usual daily physical, social, and recreational activities. The measure will be completed daily for 14 days at baseline, after phase 1, after phase 2, and 6-month follow-up
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Secondary Outcomes (7)
Change in sleep quality
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in sleep patterns
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in headache frequency
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in headache pain intensity
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
Change in anxiety symptoms
Baseline, immediately after treatment phase 1, immediately after treatment phase 2, 6-month follow-up
- +2 more secondary outcomes
Study Arms (2)
Sleep Education + CBT for Pain
ACTIVE COMPARATORParticipants will receive access to internet-delivered sleep education during Phase 1 (6 weeks) of the study followed by internet-delivered CBT for pain management during Phase 2 (6 weeks) of the study.
CBT for Insomnia + CBT for Pain
EXPERIMENTALParticipants will receive access to internet-delivered CBT for insomnia during Phase 1 (6 weeks) of the study followed by internet-delivered CBT for pain management during Phase 2 (6 weeks) of the study.
Interventions
The program delivers the core components of CBT for insomnia including sleep hygiene, stimulus control, and sleep restriction. Treatment duration is 6 weeks.
The program delivers the core components of CBT for pain management including: pain education, training in behavioral and cognitive pain coping skills, instruction in increasing activity participation, and training in parental operant and communication strategies. Treatment duration is 6 weeks.
The program delivers publicly available information about sleep.
Eligibility Criteria
You may qualify if:
- years old
- Headache present for at least three months and insomnia symptoms for the past month
- Access to the Internet on any web-enabled device
You may not qualify if:
- Non-English speaking
- Diagnosed sleep disorder (e.g. sleep apnea, narcolepsy)
- Unable to read at 5th grade level or complete surveys independently
- A serious comorbid chronic condition (e.g., diabetes, arthritis, cancer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seattle Children's Hospitallead
- University of Virginiacollaborator
Study Sites (1)
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Related Publications (1)
Law EF, Ritterband L, Zhou C, Palermo TM. Intervention for Sleep and Pain in Youth (ISPY-RCT): protocol for a two-phase randomized controlled trial of sequenced cognitive-behavioral therapy for insomnia and pain management in adolescents with migraine. Trials. 2023 Jan 12;24(1):25. doi: 10.1186/s13063-022-07035-9.
PMID: 36635741DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Law, PhD
Seattle Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Because all study procedures delivered online, neither study participants nor investigators. care providers, or outcomes assessors will have knowledge of the treatment assignment and thus this trial can be carried out as a double-blinded RCT.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 8, 2021
First Posted
June 23, 2021
Study Start
October 1, 2021
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
December 17, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share